What is the primary purpose of consolidation cytarabine administration in the treatment of adults with acute myeloid leukemia, according to a poster discussion at ASCO 2023 titled "Outcomes of 3- versus 5-day administration schedule of consolidation cytarabine in adults with acute myeloid leukemia"?